Neurocrine Biosciences (NASDAQ: NBIX) delivered a decisive earnings beat in Q3, posting adjusted EPS of $2.17 against ...
The Nashville, Tennessee-based company operates general and acute care hospitals, outpatient healthcare facilities, and behavioral hospitals, which provide therapeutic programs comprising child, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback